or
forgot password

    • cancer clinical trials in burlington, VT

    • cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Leukemia
    Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma
    University of Vermont/Vermont Children's Hospital
    Burlington, Vermont 05401
    Neuroblastoma
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Cervical Cancer
    Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Malignant Mesothelioma
    A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
    University of Vermont Department of Neurology
    Burlington, Vermont 05405
    Refractory Myasthenia Gravis
    Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma
    University of Vermont and Fletcher Allen Health Care
    Burlington, Vermont 05405
    Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    Burlington, Vermont 05401-3456
    Diabetes Mellitus
    CMX001 in Post-transplant Patients With BK Virus Viruria
    Vermont University
    Burlington, Vermont
    Viruria
    Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Endometrial Cancer
    Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma
    University of Vermont College of Medicine
    Burlington, Vermont 05405
    B-Cell Lymphoma, B-Cell Leukemia
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Outcomes of Oncology Therapy in the Elderly: Trajectory of Functional Decline and Correlates of Change
    University of Vermont/Fletcher Allen Health Care
    Burlington, Vermont 05405
    Cancer
    Safety of PCI-32765 in Chronic Lymphocytic Leukemia
    University of Vermont and Fletcher Allen Health Care
    Burlington, Vermont 05405
    B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma
    UVM/FAHC
    Burlington, Vermont 05401
    Refractory Neuroblastoma, Relapsed Neuroblastoma
    Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
    Fletcher Allen Health Care, University of Vermont
    Burlington, Vermont 05401
    Vaginitis, Dyspareunia, Breast Neoplasms
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Fletcher Allen Health Care - University Health Center Campus
    Burlington, Vermont 05401
    Breast Cancer
    Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors
    Vermont Cancer Center
    Burlington, Vermont 05401-3498
    Overweight, Postmenopausal, Breast Cancer